Marine-Derived Polysaccharide-Degrading Enzyme
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine-Derived Ingredients for Drugs, Cosmeceuticals and Nutraceuticals".
Deadline for manuscript submissions: 15 November 2026 | Viewed by 961
Special Issue Editor
Special Issue Information
Dear Colleagues,
Marine ecosystems are abundant with with high-value polysaccharides, such as alginate (from brown algae), agar/agarose and carrageenan (from red algae), ulvan (from green algae), and hyaluromic acid and chondroitin sulfate (from animals), which serve as critical resources for food, pharmaceuticals, and biorefineries. Marine-derived polysaccharide-degrading enzymes, involved in the flux of matter and energy in the global oceans, are major drivers of global biogeochemical cycling. They also have been applied in the production of pharmaceuticals, health supplements and foods through catalyzing polysaccharide degradation into bioactive oligosaccharides.
This Special Issue invites original research and reviews on the isolation, genomic/metabolomic analysis of the producers, characterization, catalytic mechanisms, fermentation and industrial applications of marine-derived polysaccharide-degrading enzymes.
Dr. Feng Han
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine-derived polysaccharide-degrading enzyme
- marine polysaccharide
- marine oligosaccharide
- marine microorganism
- genome mining
- structure–function relationship
- industrial application
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
